Cordlife Group Limited1, formerly known as “Cordlife Pte Ltd” is a leading service provider of stem cell banking from cord blood (Singapore and Hong Kong) and the umbilical cord (Hong Kong). The Company owns and operates two stem cell banks with full processing and cryopreservation storage facilities in Singapore and Hong Kong. The Company also has an investment in China Cord Blood Corporation, a top cord blood banking operator in China and the only cord blood banking operator with multiple licenses in China. The first cord blood bank to be set up in Singapore and among the first in Asia, Cordlife Group Limited’s in-depth knowledge of cord blood banking practices is widely recognised by numerous quality gold standards such as the AABB, the International Organisation for Standardisation (ISO) and in-country regulators.
Cordlife Limited is a stem cell banking company listed on the Australian Securities Exchange. A winner of Technology Pioneer award conferred by the World Economic Forum, the Group owns and operates three state-of-the-art stem cell processing and cryopreservation facilities in India, Indonesia and the Philippines.
1Cordlife Group Limited and Cordlife Limited are two separate companies. The companies are however affiliated through contractual agreements for the fulfillment of cross-border customer requests. The Cordlife brand and www.cordlife.com are properties of Cordlife Group Limited.